RAPT Therapeutics IncEigentümerstruktur
| Preis (2026-03-06) | 52W Hoch | 52W Tief |
| 58.005 USD | 58,01 USD | 8,75 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 58 USD | 1 | 1 | 4 | 1 | 0 |
| #Shares | Short [%] | Short Ratio |
| 28.960.580 | 8,59 | 0,42 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name RAPT Therapeutics Inc
Mitarbeiter 60
Handelsplatz NASDAQ
Ticker Symbol RAPT
IPO Datum 2019-10-31
Adresse 561 Eccles Avenue, South San Francisco, CA, United States, 94080
Webseite https://www.rapt.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Dr. Brian Russell Wong M.D., Ph.D. | CEO, President & Director |
| 2 | Mr. Rodney K. B. Young | CFO, Principal Accounting Officer & Secretary |
| 3 | Dr. William Ho M.D., Ph.D. | Strategic Consultant |
| 4 | Steve Young Ph.D. | Vice President of Technology |
| 5 | Dr. Dirk G. Brockstedt Ph.D. | Chief Scientific Officer |
| 6 | Mr. Michael Listgarten | General Counsel |
| 7 | Ms. Gwen R. Carscadden | Chief Human Resources Officer |
| 8 | Dr. Paul Kassner Ph.D. | Senior Vice President of Biology |
| 9 | Ms. Jennifer Nicholson | Senior Vice President of Regulatory Affairs & Quality Assurance |
| 10 | Dr. Nipun Davar MBA, Ph.D. | Senior Vice President of Technical Operations |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | TCG Crossover Management, LLC | 0,00% | 0,00 Mio. USD |
| 2 | FCPM III SERVICES BV | 0,00% | 0,00 Mio. USD |
| 3 | Orbimed Advisors, LLC | 0,00% | 0,00 Mio. USD |
| 4 | RTW INVESTMENTS, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Foresite Capital Management VI LLC | 0,00% | 0,00 Mio. USD |
| 6 | Siren, L.L.C. | 0,00% | 0,00 Mio. USD |
| 7 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 8 | Frazier Life Sciences Management, L.P. | 0,00% | 0,00 Mio. USD |
| 9 | BRAIDWELL LP | 0,00% | 0,00 Mio. USD |
| 10 | Redmile Group, LLC | 0,00% | 0,00 Mio. USD |
| 11 | Soleus Capital Management, L.P. | 0,00% | 0,00 Mio. USD |
| 12 | Nantahala Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 13 | Ikarian Capital, LLC | 0,00% | 0,00 Mio. USD |
| 14 | Caligan Partners LP | 0,00% | 0,00 Mio. USD |
| 15 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 16 | Great Point Partners LLC | 0,00% | 0,00 Mio. USD |
| 17 | Octagon Capital Advisors LP | 0,00% | 0,00 Mio. USD |
| 18 | ADAR1 Capital Management LLC | 0,00% | 0,00 Mio. USD |
| 19 | BOONE CAPITAL MANAGEMENT LLC | 0,00% | 0,00 Mio. USD |
| 20 | Susquehanna International Group, LLP | 0,00% | 0,00 Mio. USD |